Updated 02:01 GMT, 17 Nov 2026 SPX 7,416.59 -1.92% NDX 27,197.15 -2.67% VIX 22.91 +18.70% GOLD 3,868.50 -0.46% CL 85.14 -3.86% BTC 65,305.22 0.00%
NAS100 27,197 −2.67% S&P 7,417 −1.92% GOLD $3,869 −0.46% BTC $65,305 VIX 22.91 +18.70% latest tape · as of 02:01 UTC
The Screen · Financials · Asset Management

Carlyle Group Inc logoCarlyle Group Inc

CG · NASDAQ · USD · Market cap $14.6B · 2,500 employees

The Carlyle Group Inc.

FAIL · Does not pass the screen
39.77 USD

Price as of 13 Nov 2026Daily close, not a live quoteLast reviewed 4 days ago

Screened 2026-11-13 · the tape above runs as of 02:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price39.77 USD at the 13 Nov 2026 close
  • Our value readUndervalued vs our fair value, as of 13 Nov 2026
  • Our regime readMarkup, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • OptionsOpen interest leans to puts (put/call 2.15)
  • Last reviewed13 Nov 2026 (4 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: $54.53 to $79.54, base estimate $60.00 (screen dated 2026-11-13).

Current read
Markup ?
Undervalued · screened 2026-11-13
  • Trend Markup
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options put/call open interest 2.15, read 2026-11-13
  • Ethical does not pass the values gate
Price39.77 USD
Fair value60.00
Ethical score30.0/100
Value readUndervaluedas of 13 Nov 2026
Our investment reviews on this name
2026-11-01Read Markup40.18-1.0% to today Markdown gives way to Markup first Markup read since August
2026-10-02Read Markdown39.52+0.6% to today Markup gives way to Markdown after a 20% slide in 5 weeks
2026-08-25Read Markup49.37-19.4% to today Markdown gives way to Markup after an 8% rise in 8 weeks
2026-07-02Read Markdown45.75-13.1% to today ✓First review on file: Markdown

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markup label.

Carlyle Group Inc holds its Markup at $39.77. Consolidating, no directional conviction, held for 6 days.

As held on the ledger · 2026-11-13
PhaseMarkup
Quantitative stateConsolidating, no directional conviction, held for 6 days
Price at the screen$39.77
Valuation43.28 trailing · 8.48 forward price to earnings
Values screenFAIL · score 30.0
Beta1.83
The Workings

Five Screens, Shown in Full

Does not pass. Excluded industry: Asset Management

TestFigureLimitWhat it meansStatus
Business activity Excluded Core business clean Excluded industry: Asset Management Fail
Debt load Excluded Below 33% Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash Excluded Below 33% Interest-bearing cash and securities are of assets, above the one-third limit. Fail
Receivables Excluded Below 49% Money owed to the company is of assets, above the 49% limit. Fail
Revenue purity Excluded Below 5% of revenue comes from non-compliant sources, over the 5% line. Fail

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

Carlyle does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.

Read as at 2026-11-15. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when CG's ethical verdict changes

Today CG does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

The Conscience Overlay What do these labels mean?
Conscience flag · AFSC Investigate

The quantitative screen above is arithmetic. Separately, community boycott lists cite this company: Documented on AFSC Investigate. The desk records that flag here without folding it into the verdict: the screen measures the balance sheet, the overlay informs the conscience, and they are different judgements that belong to different owners. The second one is yours.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Undervalued vs our fair value, as of 13 Nov 2026: it trades at roughly a 34% discount to our $60.00 fair value, narrow competitive moat.

How a fair value is estimated: discounted cash flow (DCF).

54.53Conservative60.00Base case79.54Growth case 39.77Price

Fair value range in USD, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. A 33.7% discount to the base estimate.

The Street's Range
40.00Street low 48.00Street average 73.00Street high 39.77Price

Third-party analyst targets: 19 covering, consensus Buy. The average target sits +21% from the screen price.

Reading the gap · Both our model and the analysts see meaningful upside from here.

Price History & Projections

Where our models see it going: fair-value estimate $60.00, with a range of $54.53 to $79.54, dated to the 2026-11-13 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Private Equity Giant Fails Core Ethics Test

Money from pensions and sovereign funds flows through Carlyle into buyouts and credit plays across the globe. The firm looks cheap on a 9.1 times forward multiple with a 17 percent profit margin, yet revenue has collapsed 94 percent and the business sits in an excluded industry.

We pass outright. Asset management is on the banned list, so the 44 percent gap to our fair value and the buy-rated analyst targets do not matter. The narrow moat and 9 percent ROE simply reinforce the decision.

Cyclical fee income and carried-interest swings can turn fast when markets wobble, and currency or deal-flow shocks hit emerging exposures hard. Low multiples on distressed earnings have trapped investors before. Analysis, not advice.

The fundamentals · plain-English read
Forward P/E8.5xvery cheap relative to earnings
Trailing P/E43.3xexpensive: the price assumes strong growth ahead
EPS, trailing0.95
EPS, forward4.85
Revenue growth-18.5%revenue is shrinking
Profit margin12.8%thin but positive margins
Return on equity5.2%a modest return on shareholder capital
Dividend yield3.13%
Debt to equity2.30heavy leverage: higher risk if revenue softens
Current ratio1.96healthy short-term liquidity
Beta1.83much more volatile than the market
Short interest, float0.08%
52-week range35.41 - 67.30
MoatNARROW
Market cap$14.6B
Employees2,500

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The things to watch: it already moves more than the market on an average day; it carries a real debt load, which raises the stakes if revenue slips.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

CG trades on NASDAQ. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-12 Markup $41.12 -3.8% Entry 18

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 3.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (16 analysts) rates it buy, with a mean price target of $60.

2026-11-05 Markup $42.75 +4.5% Entry 17

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 4.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (16 analysts) rates it buy, with a mean price target of $60. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-04 Markup $40.90 +1.8% Entry 16

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 1.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (16 analysts) rates it buy, with a mean price target of $60. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-03 Markup $40.18 +0.0% Entry 15

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (16 analysts) rates it buy, with a mean price target of $60. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-02 Markup $40.18 +0.0% Entry 14

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (16 analysts) rates it buy, with a mean price target of $60. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-01 Markup · changed $40.18 +0.0% Entry 13

The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (16 analysts) rates it buy, with a mean price target of $60. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-31 Markdown $40.18 +2.9% Entry 12

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 2.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (16 analysts) rates it buy, with a mean price target of $60. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-30 Markdown $39.06 +0.0% Entry 11

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (16 analysts) rates it buy, with a mean price target of $60. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-29 Markdown $39.06 +7.4% Entry 10

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 7.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (16 analysts) rates it buy, with a mean price target of $60. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-28 Markdown $36.38 +0.0% Entry 9

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (16 analysts) rates it buy, with a mean price target of $60. It reported earnings in this window, a natural checkpoint for the thesis.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on CG

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in CG's Space

Screened names in the same industry · explore each on its own page.

The Political Ledger · Congressional Disclosures
Disclosures naming CG
DatePoliticianPartyTypeAmount
2026-06-16 Gil Cisneros Democrat buy 1K–15K
2026-06-16 Gil Cisneros Democrat sell 1K–15K
2026-06-16 Matt Van Epps Republican sell 1K–15K
2026-06-16 Matt Van Epps Republican sell 1K–15K
2026-06-15 Cleo Fields Democrat buy 1K–15K
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $49.10 -9.8% $0.35 $909 -9.1%
2 months $46.95 -5.7% $0.35 $950 -5.0%
3 months $44.98 -1.6% $0.35 $992 -0.8%
6 months $59.36 -25.4% $0.70 $758 -24.2%
1 year $45.62 -3.0% $1.40 $1,001 +0.1%
2 years $38.50 +15.0% $2.80 $1,222 +22.2%
3 years $27.36 +61.8% $4.20 $1,771 +77.1%
5 years $37.68 +17.5% $6.60 $1,350 +35.0%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever CG does next, these words stay.

Carlyle Group Inc · CG · Markup · $39.77
Recorded 2026-11-13 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.